Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01030653Phase 4Completed
Phase 4, randomised, open-label trial of voriconazole in fungal infection (2 arms). Primary endpoints: Steady-State Maximum Plasma Concentration at Day 5, Steady-State Minimum Plasma Concentration at Day 5 and 1 more. Started Nov 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01030653.